Accueil   Diary - News   All news Nosopharm welcomes Jacques Biton and Frédéric Hammel to its supervisory board

Nosopharm welcomes Jacques Biton and Frédéric Hammel to its supervisory board


Jacques Biton appointed chairman

 


Lyon, France, November 5, 2019 – Nosopharm, a company dedicated to the research and development of new anti-infective drugs, today announces changes to its supervisory board: Jacques Biton has been appointed as chairman, taking over from Gilles Alberici, while Frédéric Hammel joins the board as a member, representing Elaia Partners. These appointments were effective from the start of October.

 


Both appointments come in a year when Nosopharm has signed a major agreement with Evotec and set as short- and medium-term goals a further round of financing and new strategic partnerships. In the longer term, the company plans to expand its pipeline and to license its drug candidates and drug discovery platform.

 


“I am delighted to welcome Jacques Biton and Frédéric Hammel to the supervisory board of Nosopharm. I would also like to thank Gilles Alberici, who has helped us achieve a major milestone in our development this year with the Evotec partnership, and Franck Lescure, for his support in growing the Nosopharm business,” said Philippe Villain-Guillot, chairman of the Nosopharm management board. “Jacques and Frédéric will help us to maintain this momentum and strike new agreements with biotechnology and pharmaceutical companies. Their experience and expertise will be crucial in achieving our future goals.”

 

 

 

 

Read the press release

 

 

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree